Skip to content
DraconiticResearch
Search Sources API
181,716 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BY 4.0Veterinary Pathology

Clinicopathological characteristics and clinical outcomes of multiple histological subtypes in feline mammary carcinomas

  1. 1Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand
  2. 2Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand
  3. 3Veterinary Diagnostic Laboratory, Michigan State University, East Lansing, MI

Abstract

Feline mammary carcinomas (FMCs) are heterogeneous neoplasms often comprising multiple histological patterns within a single case. The current practice of focusing on a prominent subtype hinders prognostic accuracy and potentially produces suboptimal therapeutic decisions. This retrospective study proposed criteria for grouping these mixed patterns and evaluated their prognostic significance in FMCs. The criteria were based on the tubular carcinoma composition and adopted from those of human breast cancer. Eighty-seven cats with FMCs were divided into groups according to tubular carcinoma composition: pure tubular carcinoma (PTC, n = 34), tubular carcinoma mixed with other subtypes (TMC, n = 16), and nontubular carcinoma (NTC, n = 37). Prognostic factors and overall survival (OS) were compared among the groups. The PTC and TMC groups were significantly associated with early-stage FMCs (P = .03) and low argyrophilic nucleolar organizer region values (P = .02). Conversely, NTCs had the poorest prognosis (P = .03) and were associated with incomplete surgical margins (P = .004), advanced clinical stage (P < .001), and high histological grade (P < .001) on multivariable analysis. Median OS for the PTC, TMC, and NTC groups was 221, 242, and 147 days, respectively. Considering individual histological subtypes, cats with adenosquamous carcinoma had a shorter OS (60 days) than those with comedocarcinoma (147 days) and tubular carcinoma (240 days, P < .001). These criteria were associated with FMC outcome in this cohort, providing a potentially useful framework for prognosis. However, further validation through prospective studies is needed to fully establish their clinical utility.

Related

  1. Clinicopathological characteristics and outcomes of rectal neuroendocrine tumors according to resection modality.
    Wanrong Zhou, Qi Cheng, Xiaolin Lin +5
    International journal of colorectal diseasePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  2. Clinicopathological Profile, Treatment Patterns and Documented Clinical Outcomes of Women with Breast Cancer at Shendi Hospital, Sudan: A Retrospective, Single-Center, Hospital-Based Cross-Sectional Study.
    Elryah I Ali, Saadalnour Abusail Mustafa, Husham O Elzein +7
    Breast cancer (Dove Medical Press)Peer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  3. An interpretable cell-centric representation of pancreatic ductal adenocarcinoma matches multiple-instance learning for clinical outcomes and leads to novel pathologist-driven histological biomarkers
    M. Pelloux, C. T. Tran, J. Baig +16
    medRxivPreprintCC BY-NC-NDFull textGeneral medicinemedRxiv
  4. Maternal characteristics, clinical indications, and neonatal outcomes in cesarean hysterectomy: A cross-sectional study
    Farahnazsadat Ahmadi, Behnaz Behzadi, Mahboubeh Tajaldini
    International journal of reproductive biomedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Lower-extremity Deep Vein Thrombosis after Plastic Surgery: Clinical Characteristics and Outcomes in a Retrospective Case Series
    Yuan Chen, Ronghao Ouyang, Hang Zhang +4
    Plastic and reconstructive surgery. Global openPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMC
BibTeX
@article{aruvornlop2026clinicopathological,
  title = {{Clinicopathological characteristics and clinical outcomes of multiple histological subtypes in feline mammary carcinomas}},
  author = {Pruettha Aruvornlop and Nlin Arya and Sirintra Sirivisoot and Tanit Kasantikul and Rassameepen Phonarknguen and Walasinee Sakcamduang},
  journal = {Veterinary Pathology},
  year = {2026},
  month = jul,
  doi = {10.1177/03009858261462564},
  url = {https://doi.org/10.1177/03009858261462564},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Clinicopathological characteristics and clinical outcomes of multiple histological subtypes in feline mammary carcinomas
AU  - Pruettha Aruvornlop
AU  - Nlin Arya
AU  - Sirintra Sirivisoot
AU  - Tanit Kasantikul
AU  - Rassameepen Phonarknguen
AU  - Walasinee Sakcamduang
PY  - 2026
DA  - 2026/07/13
JO  - Veterinary Pathology
DO  - 10.1177/03009858261462564
UR  - https://doi.org/10.1177/03009858261462564
AB  - Feline mammary carcinomas (FMCs) are heterogeneous neoplasms often comprising multiple histological patterns within a single case. The current practice of focusing on a prominent subtype hinders prognostic accuracy and potentially produces suboptimal therapeutic decisions. This retrospective study proposed criteria for grouping these mixed patterns and evaluated their prognostic significance in FMCs. The criteria were based on the tubular carcinoma composition and adopted from those of human breast cancer. Eighty-seven cats with FMCs were divided into groups according to tubular carcinoma composition: pure tubular carcinoma (PTC, n = 34), tubular carcinoma mixed with other subtypes (TMC, n = 16), and nontubular carcinoma (NTC, n = 37). Prognostic factors and overall survival (OS) were compared among the groups. The PTC and TMC groups were significantly associated with early-stage FMCs (P = .03) and low argyrophilic nucleolar organizer region values (P = .02). Conversely, NTCs had the poorest prognosis (P = .03) and were associated with incomplete surgical margins (P = .004), advanced clinical stage (P < .001), and high histological grade (P < .001) on multivariable analysis. Median OS for the PTC, TMC, and NTC groups was 221, 242, and 147 days, respectively. Considering individual histological subtypes, cats with adenosquamous carcinoma had a shorter OS (60 days) than those with comedocarcinoma (147 days) and tubular carcinoma (240 days, P < .001). These criteria were associated with FMC outcome in this cohort, providing a potentially useful framework for prognosis. However, further validation through prospective studies is needed to fully establish their clinical utility.
SN  - 0300-9858
SN  - 1544-2217
ER  -